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Female  protein  (FP) 1 is  a  fast  alpha globulin  present  in  generous  amounts  (1-2 
mg/ml) in sera of normal female Syrian hamsters and not detectable by gel diffusion 
in  sera  of normal  adult  males  (1).  Serum  FP  in  normal  males  is  suppressed  by 
testosterone as FP did appear in male hamsters after diethylstilbesterone treatment or 
castration and subsequently disappeared after exogenous testosterone administration 
(1). Other examples of sex hormone-controlled serum proteins have been documented 
in cockroaches (2) and chickens (3) where the protein was involved with egg produc- 
tion  (4).  The sex difference of mammalian serum proteins  (Ss  protein  [5],  IgM  [6], 
various  complement  components  [7,  8])  has  not  been  related  to  any  particular 
functional requirement unique  for one sex. Similarly, we are not aware of a  unique 
biological difference between  male and  female hamsters that  could be functionally 
related to presence or absence of FP, and this protein  did not  appear analogous to 
any of the previously described sex-limited proteins in  mammals. However, during 
the structural  analysis of FP, some unusual  properties were found which  suggested 
the relationship of FP to a well known acute-phase protein, C-reactive protein (CRP). 
Accordingly,  FP  was  studied  to  determine  binding  characteristics,  appearance  in 
electron  microscopy, subunit  structure,  and  primary amino  acid  sequence.  In  this 
report, FP is shown to be functionally, morphologically, and structurally similar to 
two  related  proteins,  CRP  and  serum  amyloid  P  component  (SAP).  In  fact,  FP 
appears to represent the CRP-SAP homologue in Syrian hamsters. 
Materials and Methods 
Animals. Random-bred Syrian hamsters were obtained from the National Institutes of  Allergy 
and Infectious Diseases, (NIAID), Rocky Mountain Laboratory colony and New Zealand white 
rabbits were purchased locally. 
1  Abbreviations used in this paper: CRP, C-reactive  protein; DTT, dithiothreitol; EDTA-E, EDTA column 
eluate; FP, female protein; HEA, hen egg albumin; IEP, immunoelectrophoresis; NFHS, normal female 
hamster serum; NHS, normal hamster serum; PAGE, polyacrylamide  gel electrophoresis; PBS, phosphate- 
buffered saline; PC,  phosphoryleholine; PT,  pass-through; PTH,  phenylthiohydantoin; RGG, rabbit 
gamma globulin; SAP, serum amyluid P (component); SDG, sucrose density gradient; SDS-PAGE,  sodium 
dodecyl sulfate-PAGE. 
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Antisera and Purified Proteins.  Anti-whole normal hamster serum  (NHS)  was produced by 
inoculating a Targhee sheep with pooled normal male and female hamster serum in complete 
Freund's  adjuvant.  This  sheep  antiserum  contained  antibody to  FP  which  was  especially 
apparent  on  immunoelectrophoresis  (IEP)  because  of low  anti-albumin  content.  Antisera 
specific for FP were obtained by absorption as previously described (1) or utilized serum from 
rabbits inoculated with purified preparations of FP emulsified in complete Freund's adjuvant. 
Anti-B1C was produced by injecting rabbits with washed zymozan after treatment with hamster 
serum (9). Anti-human amyloid P component purchased from Atlantic Antibodies, Westbrook, 
Mass., and generously supplied by Dr. Painter (University of Toronto, Toronto, Canada) were 
utilized. Anti-human CRP (Behring Diagnostics, Inc., Woodbury, N. Y.) and purified human 
CRP,  rabbit CRP, and pneumococcai C-polysaccharide were obtained from Dr. H. Gewurz 
(Rush Medical College, Chicago, Iil.). 
Serum Fractionation.  Normal female hamster serum (NFHS; 4 ml) was filtered through a 2.5- 
×  90-cm column of Sephadex G-200 (Pharmacia Fine Chemicals, Uppsala, Sweden) with 1 M 
NaCI-Tris, pH 8.0 solution, and 2.5-ml fractions were collected. NFHS (0.3 ml) was analyzed 
on  a  10-40%  sucrose density gradient  (SDG)  spun  at  35,000  rpm  with  SW50.1  rotor in  a 
Beckman L2-65B ultracentrifuge (Beckman Instruments Inc., Fullerton, Calif.). DEAE-purified 
rabbit gamma globulin (RGG;  Pentex Biochemicals, Kankakee, II1.) and hens' egg albumin 
(HEA; ICN K  and K  Laboratories Inc., Plainview, N. Y.) were labeled with 131I or 1251 (ICN, 
Irving, Calif.) respectively by chloramine T  (10) or KI (11) methods and incorporated with the 
sample as markers. Equal fractions recovered from the bottom of the tube, were assayed for 
radioactivity in dual-channel Nuclear Chicago automatic gamma counter and FP was quan- 
tified by ring diffusion analysis (1). 
Affinity Chromatography  of  FP.  FP was isolated by passing NFHS through a column containing 
Sepharose  2B  conjugated  by  cyanogen  bromide with  specific rabbit  anti-FP as previously 
described (1). Pure FP was obtained also by affinity chromatography using phosphorylcholine 
(PC) conjugated to Sepharose prepared according to the method of Chesebro and Metzger (12) 
and kindly supplied by Dr. B. Chesebro. In preparative use, NFHS (5 ml) was passed through 
a column containing 30 ml PC-Sepharose previously equilibrated with 0.5 mM CaCI~, 0.1  M 
Tris buffer, pH  7.0.  After thorough  washing  (400  ml) with the same buffer,  FP was eluted 
either with 0.001  M  phosphorylcholine (PC:) (ICN Pharmaceuticals, Plainsview, N. Y.)  in the 
same CaCl~-Tris buffer or with 0.1 M EDTA in 0.1 M Tris, pH 7.0. The eluate was concentrated 
by  negative  pressure  and  dialyzed against  phosphate-buffered  saline  (PBS),  pH  7.2.  For 
comparative purposes,  a  7-ml column  of plain  Sepharose  (Sepharose 4B,  Pharmacia,  Fine 
Chemicals) and a  7-ml column of PC-Sepharose were tested for their relative yield of FP after 
addition of 1 ml NFHS, using similar buffer and elution scheme as presented above. 
Analytical Techniques.  Immunoelectrophoresis, simple gel diffusion, and ring diffusion quan- 
tification assays were done as before (1). Polyacrylamide gel electrophoresis (PAGE) (13) and 
sodium dodecyl sulfate (SDS-PAGE) (14) with 5, 7, or 10% gels used a Bio-Rad vertical slab gel 
apparatus (Bio-Rad Laboratories, Richmond, Calif.). Gels were stained with Coomassie Blue 
(15) and molecular weight-marker proteins were obtained from Boehringer Mannheim. Purified 
FP was labeled with l~I-Bolton Hunter reagent (New England Nuclear, Boston, Mass.) and 
after disk SDS-PAGE, the gel was fractionated by Savant Autogeldivider (Savant Instruments, 
Inc., Hicksville, N. Y.). 
Electron Microscopy.  Electron microscopy was carried out on a Philips 300 electron microscope 
(Philips Electronic Instruments, Inc., Makwah, N. J.) at 80 Kv with a 70-#m objective aperture 
and  a  magnification of 27,000-40,000  times.  Calibration was  based  upon  photographs  of 
indanthrene olive crystals (16).  Micrographs were recorded sufficiently close to focus to make 
metal grain at  the 2.0-nm  level clearly resolved on the original plates. Solutions of protein, 
dialyzed exhaustively against 0.15  M  ammonium acetate were sprayed at a  concentration of 
~0.1  mg/ml  through  a  high-pressure spray gun  at  freshly cleaved mica.  Preparations were 
either shadow cast with platinum by rotary shadowing as described previously (17) or negatively 
contrasted by the method of Valentine et al. (18). 
In making the measurements from the micrographs, a number of entire fields was scored in 
order to reduce selectivity. From similarly prepared samples of other molecules of known size J.  E.  COE,  S.  S.  MARGOSSIAN, H.  S.  SLAYTER, AND JOHN  A.  SOGN  979 
and shape (17), a correction of 2.5 nm was applied to compensate for the distortion in thickness 
of the original particles by the cap of replicating metal. 
Molecular Weight Determination of FP.  Molecular weight determinations were done by the 
high-speed meniscus-depletion  method (19) using Beckman Model E analytical ultracentrifuge 
equipped with Rayleigh interference optics. 
A six-channel, externally loading cell with sapphire windows (20) was filled with protein at 
three initial concentrations (0.10, 0.30, and 0.72 mg/ml). The AN-E rotor was accelerated to 
15,000 rpm at 5°C and at equilibrium, pictures were taken on Kodak Nuclear Medicine film 
or type IIG spectroscopic plates (Eastman Kodak Co., Rochester, N. Y.) at camera focus of 2/ 
3 plane (19, 21). The molecular weight was calculated by linear regression  analysis, from the 
equation 
mol wt = 
2RT  (dlog c'~ 
(1--rep)w2 ×2"303\  dr  2  ], 
where R =  gas constant; T -- absolute T°; ~ -- partial specific volume of solute; p =  density of 
solution; c  =  concentration of protein; r  =  radial distance; using a  value of 0.728  cc/g for 
partial specific volume. To determine the molecular weight of FP subunits, the protein also was 
analyzed in 5 M  guanidine hydrochloride, 20 mM sodium phosphate, pH 7.0, at two initial 
protein concentrations of 0.30 and 0.70 mg/ml. 
Amino Acid Analysis.  Two independent preparations of FP were analyzed. Aliquots of each 
preparation were  hydrolyzed for  16,  24, and 72  h  in vacuo in 6 N  HCI, to obtain accurate 
values for labile and slowly released amino acids. Amino acid compositions were determined 
using a Durrum D-500 amino acid analyzer (Durram Instrument Corp., Sunnyvale, Calif.). 
Sequence Determination.  A sample of 8 mg of FP was dissolved in 0.5 m[ of 0.3 M Tris, pH 8.2, 
containing  6 M guanidine-HCl, reduced under N2 with 0.02 M dithiothreitol (DTT) for 1 h at 
0°C and alkylated with 0.042 M iodoacetamide at 0°C for  1 h. The protein was then dialyzed 
against 0.05 M sodium borate, pH 8.5 and succinylated with a large excess of succinic anhydride 
in a pH-stat at pH 10.5. The succinylated protein was deblocked (22), dialyzed against water, 
lyophilized and subjected to 25 cycles of the Edman degradation in a modified Beckman 890C 
sequencer using a  0.1  M  quadrol  program.  Phenylthiohydantoin (PTH)  amino acids were 
identified by liquid chromatography using the method of Gates et al. (23). 
Results 
Functional Studies of FP Binding.  NFHS (1.0 ml) was passed through a  7-ml column 
of PC-Sepharose previously equilibrated with 0.5 mM CaC12  in 0.1  M  Tris HCI, pH 
7.0. After further washing (100 ml) with the same buffer, 0.1  M  Na EDTA, pH  7.0 
was added to the column. The collected pass-through and EDTA eluate volumes were 
concentrated to  1 ml, dialyzed against PBS,  and tested  for  presence of FP.  Fig.  1 
Fro.  1.  Selective removal of FP by passage of NFHS through PC-Sepharose in presence of Ca  ++. 
IEP comparing the original NFHS (center well, female hamster serum (9 HS)) with that portion 
which passed through  (PT,  top  well) the  PC-Sepharose column and that  portion which was 
subsequently eluted with EDTA (EDTA-E, bottom well). Notice the FP precipitin line is absent in 
PT and is the only detectable protein in EDTA eluate. Hamster albumin precipitin line not detected 
with this sheep anti-NHS (in troughs). 980  HAMSTER FEMALE PROTEIN 
TABLE I 
Differential Elution of FP and Other Proteins  from PC- and Plain Sepharose Column 
Elution scheme 
PC-Sepharose  Plain Sepharose  Glass bead 
FP  Other proteins  FP  Other proteins  FP  Other proteins 
EDTA  + *  +  +  +  0  0 
PC  +  0  +  0  0  0 
EDTA after PC  0  +  0  + 
PC after EDTA  0  0  0  0 
* +, present; 0, absent. 
shows an IEP comparing the original serum in the center well, the pass-through of the 
PC column  (PT) in the top well and the EDTA eluate of the column  (EDTA-E)  in 
the bottom well. When  developed with sheep anti-NHS, the FP precipitin  line was 
seen  in  the  original  serum,  was  singularly  absent  from  the  PT  and  was  the  only 
protein present in the EDTA eluate. Thus, FP binds to PC-Sepharose in a  calcium 
dependent fashion. Analysis of EDTA eluates by simple gel diffusion and PAGE did 
reveal the presence of minor contaminants (Table I). 
If PC were the binding ligand  for FP, then  free PC should elute bound FP from 
PC-Sepharose.  NFHS  was  added  to  a  PC-Sepharose  column  as  before  and  after 
washing with CaC12/Tris buffer, the column was eluted with 0.001  M  PC in the same 
CaCl2/Tris buffer. FP was the only protein in the PC eluate by simple gel diffusion 
and PAGE analysis (Table I). Furthermore, no additional FP could be recovered from 
the  column  by  subsequent  elution  with  EDTA-Tris  buffer,  although  this  eluate 
contained  small amounts of B1C  and,  occasionally, albumin.  Therefore, free PC  in 
the presence of Ca  ++ eluted all the FP bound to PC-Sepharose and FP was the only 
protein in this eluate (Table I). 
Next, NFHS was passed through a  7-ml plain Sepharose column under the same 
buffer conditions to test whether PC was indeed the binding ligand in PC-Sepharose 
chromatography.  Small amounts of FP were recovered in  the EDTA eluate  (along 
with trace amounts of previously noted contaminants). As with the PC-Sepharose, all 
of the  FP  without  contaminants  could  be eluted  with  0.001  M  PC  in  CaC1JTris 
buffer (Table I). To determine if the glass column itself was responsible for any FP 
binding,  whole  female serum  was  passed  through  a  100-ml  column  of glass  beads 
under usual buffer conditions. No FP was lost from the PT or detected in the EDTA 
eluate.  Thus,  FP  does bind  to  Sepharose in  a  Ca++-dependent  fashion  and  can  be 
specifically eluted with free PC. A summary of these results is shown in Table I. 
Further quantitative assays were done comparing FP ~'ield with PC-Sepharose and 
plain Sepharose absorption  under varying concentrations of Ca  ++ and  PC.  1 ml of 
pooled NFHS was filtered through a 7-ml column of PC-Sepharose or plain Sepharose 
and, under similar conditions, the PT and eluted FP were collected, concentrated and 
quantified by ring-diffusion assay. The total recovered FP (PT plus eluate) averaged 
70% with both columns and was similar at various Ca  ++ concentrations. The results, 
expressed as milligrams of FP in PC-eluate, are shown in Table II. At the optimum 
Ca  ++  concentration  (0.5  mM),  a  comparable volume of PC-Sepharose bound  -15 
times more FP than plain Sepharose (0.86 mg vs. 0.05 mg). The Ca  ++ dependence of 
binding was biphasic, with no binding at low concentrations (0.05 mM) and reduced j.  E.  COE,  S.  S.  MARGOSSIAN, H.  S.  SLAYTER, AND JOHN  A.  SOGN 
TABLE II 
Relative YieM  of FP  from PC-Sepharose  and Plain Sepharose Columns by 
PC Elution in  Various Concentrations of Ca ++* 
Ca  ++  PC-Sepharose  Plain Sepharose 
50 mM 
rag FP in PC-eluate 
0.34  0.09 
0.43  0.08 
0.19  0.05 
981 
5 mM  0.53 
0.5 mM 
0.92  0.03 
0.97  0.02 
1.12  0.09 
0.53  0.05 
0.61  0.25 mM  1.15 
<0.01  <0.01  0.05 mM 
<0.01  <0.01 
* Conditions: columns (7 ml each) received 1 ml pooled NFHS that contained 
1.5 mg FP/ml, and were eluted with PC (10-  M, preceded by 10  -4 M in 
some cases) and then EDTA. FP was never detected in the EDTA eluate 
when preceded by PC elution. Some columns were eluted with 10  -4 M before 
10  -s M PC and the respective amounts of eluted FP were quantified. In 50 
mM Ca *+, 10  -4 M PC did not elute FP from PG-Sepharose, although with 
plain Sepharose, equal amounts of FP were eluted with 10  -4 M and subse- 
quent 10  -a M PC (three columns each). In 0.5 mM Ca  ++, distribution of FP 
in 10  -4 M and subsequent 10  -a M PC elution from PC-Sepharose was 70- 
73% and 30-27%, respectively (two columns) whereas with plain Sepharose, 
all FP was eluted at 10  -4 M PC (two columns). 
binding at high concentrations (50 mM). A concentration of 10  -a M  PC was sufficient 
to  remove  all  FP,  as  subsequent  EDTA  eluates  of all  columns were  consistently 
negative (data not shown). PC was partially effective at  10  -4 M  in recovery of FP, 
especially in 0.5 mM Ca  ++, where all (plain Sepharose) or part (PC-Sepharose) of the 
FP  was  eluted.  At  50  mM  Ca  ++,  partial  (plain Sepharose)  or  no  (PC-Sepharose) 
elution was found at  10  -4 M  PC. These results suggest a greater affinity of FP for PC- 
Sepharose than plain Sepharose and, although Ca  ++ is necessary, optimum binding 
to PC-Sepharose occurs with intermediate Ca  ++ concentration (0.5 mM). 
Gel Diffusion  Tests with FP.  CRP complexes in a Ca++-dependent fashion with PC 
residues of pneumococcal C-polysaecharide (24, 25). However, when FP was tested on 
simple  gel  diffusion  (5  mM  Ca++-agarose)  against  purified  C-polysaccharide,  no 
precipitin reaction was detected with various purified and unpurified preparations of 
FP. A  satellite well of FP did not alter or interfere with the precipitin line produced 
by  human  CRP  and  C-polysaccharide.  Rabbit  CRP  did  produce  a  detectable 
precipitin line with this C-polysaccharide, although rabbit CRP  reacts better with 
the less-degraded form of C-polysaccharide (26). Antigenic determinants common to 
FP and CRP  or amyloid P  component were not detected by gel diffusion assay as 
anti-CRP and anti-amyloid P component did not cross-react with FP and rabbit anti- 
FP did not precipitate CRP. 982  HAMSTER FEMALE  PROTEIN 
Fro.  2.  Electron  micrographs of hamster FP negatively contrasted with uranyl acetate. Field: x 
134,784; insets: X 494,208. 
Electron Microscopy.  In  negatively  stained  preparations,  FP  appears  roughly as  a 
toroidal  or  pentagonal  object  -t0-13  nm  in  diameter  (Fig.  2).  This  dimension 
depends upon whether the diameter is measured face-to-face or vertex-to-vertex. The 
most  frequent  vertex-to-vertex measurements  based on scoring of 200 particles  aver- 
aged  12-13  nm  with  an  SD of 1.5  nm.  Measurements  between  sides  based  on  200 
particles  were  slightly  less  and  ranged  from  10.5  to  12  nm  with  approximately  the 
same  standard  deviation.  Fig.  3  is  a  histogram  showing  the  distribution  of widths 
(face-to-face) for FP. Corrected width measurements  from rotary shadow cast prepa- 
rations were consistent with those from negatively stained material.  In the majority of 
molecular images showing polyhedral symmetry, a  pentameric structure was evident. 
In rare instances,  a  hexameric outline was seen. 
Structure.  Filtration  of NFHS  through  Sephadex  G-200  revealed  the  presence  of 
FP in a  single peak just  after the  7S peak  (Fig. 4).  By using the gammaglobulin  and 
albumin  peaks  as  markers,  the  diffusion  coefficient  was  calculated  to  be  4.4  ×  107 
(27).  When  analyzed  by  SDG  ultracentrifugation,  FP  sedimented  in  a  single  7.3S 
peak  slightly  faster  than  that  of  the  7S  marker  protein  I125-RGG  (Fig.  5).  The J.  E.  COE,  S.  S.  MARGOSSIAN, H.  S.  SLAYTER,  AND JOHN  A.  SOGN  983 
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Fie.  3.  Histogram of EM measurements showing the distribution of face-to-face diameter of FP. 
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molecular size was estimated to be  150,000 by using the above values  for diffusion 
coefficient and velocity, and assuming the partial specific volume of FP to be 0.73 
(28). 
In an effort to obtain more information concerning the size and homogeneity of 
FP, purified FP preparations obtained by affinity chromatography (anti-FP and PC 131] 
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FIG. 6.  High-speed  sedimentation equilibrium values of FP. Log c vs. r  2 plot of values. Initial 
protein concentration: 0.72 mg/ml in 0.85% NaCI. Rotor speed: 15,000 rpm at 5°C. 
affinity) were analyzed by the method of high-speed equilibrium centrifugation.  Fig. 
6  shows  that  the  log C  vs.  r 2 plot  was  linear  over the entire  length  of the  solution 
column with a  negligible curvature upward at the base of the cell, thus indicating a 
very homogenous, monodisperse preparation.  The molecular weight calculated from 
these data was  151,000, in agreement with the value estimated by other methods. 
Isolated  FP  obtained  by  affinity  chromatography  was  analyzed  by  SDS-PAGE 
with 5, 7, and  10% gels. A consistent single band was detected of ~30,000-mol wt size 
(Fig.  7)  and  a  similar  result  was  found with  or without  2-mercaptoethanol.  Other 
subunit  structures  were not detected  with  a25I-labeled FP, as a  single peak of radio- 
activity at -30,000-mol wt position was found when a25I-FP was subjected to electro- 
phoresis in disk SDS-PAGE and fractionated. j.  E.  COE,  S.  S.  MARGOSSIAN, H.  S.  SLAYTER, AND JOHN  A.  SOGN  985 
Fla.  7.  SDS-PAGE analysis of FP compared with marker protein cytochrome C (Cyto-c;  11,700), 
chymotrypsinogen  (CHYMO;  25,700), aldolase  (ALDO; 40,000),  bovine serum  albumin  (BSA; 
68,000)  and  RGG  (150,000).  In  presence  of SDS  with  or without  2-mercaptoethanol,  FP  has 
monomer subunit size of =30,000  mol wt. 
TABLE  III 
Amino Acid Compositions of FP and Two CRP 
FP* (prepara-  FP*  (prepara-  CRP*~ (rabbit)  CRP,§ 
tion  1)  tion 2)  (human) 
Asx  19.0  19.0  19.1  15 
Thr  9.8  9.1  8.7  12 
Ser  16.2  11.9  19.2  18 
Glx  26.1  28.4  19.5  20 
Pro  9.8  10.7  10.1  11 
Gly  17.9  19.1  17.6  14 
Ala  10.9  9.3  10.3  9 
Cys  NDI[  ND  ND  2 
Val  10.9  15,0  13.4  17 
Met  2.6  2.2  3.8  2 
Ile  8.2  8.4  8.4  9 
Leu  15.0  15.4  16.7  14 
Tyr  9.6  9.5  9.2  7 
Phe  9.3  8.7  11.7  12 
His  4.2  3.9  2.9  2 
Lys  13.3  11.3  13.1  12 
Arg  7.2  7.9  6.1  6 
Trp  ND  ND  ND  5 
* Composition based on number of residues/190  total residues. 
:~ From reference  (30). 
§ Composition from complete sequence (29). 
II Not determined. 
The  subunit  molecular weight  also was  calculated  from high speed sedimentation 
equilibrium runs  in 5  M  guanidine-HC1.  A  value of 30,000  mol wt was obtained  and 
did  not  change  as  the  initial  protein  concentration  was  doubled  (30,000  tool  wt  at 
0.70  mg/ml)  or when  1.0  mM  DTT  was  included  in  the solvent system  (28,200  mol 
wt).  The  above  results  then  are  consistent  with  a  model  of  the  native  molecule 
consisting  of a  pentamer  with  five 30,000-mol  wt  subunits  noncovalently  assembled 
to form the parent  molecule of 150,000  mol wt. 
Amino  Acid  Composition  and  Sequence  Analysis.  Table  III  shows  the  amino  acid 
compositions  for  two  preparations  of FP  compared  with  the  published  composition 
for human  (29)  and  rabbit  (30)  CRP.  A  significant  similarity can be seen. ~
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Two attempts to sequence unmodified FP yielded no PTH derivatives, indicating 
that  the  protein  was  blocked.  Enzymatic  deblocking  with  pyroglutamate  amino 
peptidase  permitted the determination of 23 of the first  26 residues  from the NH2 
terminus. Table IV shows the FP sequence compared to the published amino terminal 
sequences of C It (31), amyloid P'component (32), human CRP (29) and rabbit CRP 
(31)  (Clt is now known to be amyloid P component [33]).  The homology of FP and 
amyloid P component is apparent, as their sequences were identical except at the very 
beginning  and  at  residues  14,  16,  and  19.  Thus,  of 23  hamster  FP  residues,  19 
sequences  were  identical  to  amyloid  P  component  (83%).  The  homology between 
amyloid  P  component  and  CRP  has  been  previously established  with  identity at 
~50% of NH2-terminal residues (31, 32). 
Discussion 
Hamster FP is a  model example of a  sex-limited serum protein, as it is expressed 
prominently in  the  female and  testosterone suppressed  in  the  male.  However, the 
binding specificity, morphology, and  structure of FP were found to be remarkably 
similar to CRP and SAP, two related proteins that are normally present in low serum 
concentration and not known to be under sex-hormone control. Human CRP is the 
classic acute-phase reactant, which can nonspecifically increase almost  1000-fold in 
serum level after a variety of inflammatory stimulae. Yet, CRP does react in a specific, 
Ca++-dependent  fashion  with  C-polysaccharide of pneumococcus,  a  characteristic 
which led to the discovery of CRP by Tillett and Francis in  1930 (34).  Subsequently, 
numerous  investigations  have  defined  the  structure  of CRP  (29,  35),  its  binding 
properties (24, 36), its synthesis and kinetics (37-39), and have demonstrated related 
proteins in other animals (26, 40). Although the biological function of CRP remains 
an enigma, numerous biological activities have been shown including activation of 
complement  (41,  42),  interaction with  T  lymphocytes (43)  and  platelets  (44),  and 
enhancement of phagocytosis  (45).  Another related protein, called amyloid P  com- 
ponent  (31,  32),  is  found in  all  forms of human  amyloid  (46).  SAP  component  is 
found in microgram amounts in normal human and mouse serum, but only in mice 
does SAP increase as a typical acute-phase reactant after inflammatory stimulae (47). 
CRP and SAP both have a unique polygonal structure by electron microscopy, which 
prompted their designation  as  pentraxins  (31),  and  comparison  of amino-terminal 
primary structures has established their homologous relationship (3 I, 32). 
FP of Syrian hamsters is another member of this interesting family of pentraxins, 
which actually represents an unusual protein configuration (48). The electron micro- 
graphs indicate that in both morphology and dimensions, FP is very similar to CRP 
and SAP. The pentameric outline indicates the presence of five subunits, which was 
confirmed by the fact that  the molecular weight  (150,000)  is five times the subunit 
molecular weight (30,000). Thus, the noncovalent assemblage of FP subunits is similar 
to CRP  (35)  and SAP (32), although the subunit size of FP is somewhat larger than 
CRP and SAP (23,000). Also, the parent molecule of FP (150,000) is larger than CRP 
(120,000-140,000)  but smaller than SAP  (9.5S), which characteristically forms dou- 
blets of pentamers (49). 
FP binds to both PC and agarose (Sepharose) in a calcium-dependent fashion and 
thus displays the Ca++-dependent-binding specificities previously described for CRP 
(PC-binding specificity) (24,  25)  and SAP (agarose-binding specificity) (50).  The  15 988  HAMSTER FEMALE PROTEIN 
times greater elution yields of FP after binding to PC-Sepharose vs. plain Sepharose 
would indicate a greater affinity to PC ligand than to agarose. The elution by free PC 
of pure FP bound to either PC or agarose would indicate a  predominant specificity 
for  the  PC  ligand.  CRP  reacts  with  the  cell  membrane components  lecithin  and 
sphingomyelin (42)  and the capacity of CRP to affect various cellular functions may 
be directed toward these choline phosphatides. Whether FP alters cellular functions 
in a  fashion similar to CRP is currently under investigation. 
FP resembles CRP and SAP in the noncovalent binding of its monomer subunits. 
In fact, this observation was the  initial  clue that  this sex-limited protein  of Syrian 
hamsters might be related to such a disparate family of pentraxins such as CRP and 
SAP.  The  amino-terminal  sequence  data  show  a  clear homology between  FP  and 
SAP in which  19 of 23 identifiable residues  (83%)  were identical.  Larger differences 
were seen  between  FP  and  two CRP,  but  SAP  and  CRP  have been  shown  to  be 
homologous (31, 32). Thus, CRP, SAP, and FP appear to have evolved from the same 
ancestral gene, although FP superficially appears to have little in common with the 
other two acute-phase proteins primarily because (a) FP is such a conspicuous serum 
protein ('2  mg/ml) in NFHS, and (b) the synthesis or at least serum levels of FP are 
under hormonal control (testosterone suppression). Studies in humans have shown no 
apparent difference of CRP levels between sexes, although SAP levels were somewhat 
higher in normal males (43 #g/ml) vs. females (33 #g/ml)  (51). In the mouse, where 
SAP is an acute-phase reactant, comparable levels were detected in stimulated male 
and female mice (47).  Hamster FP does have a  semblance of acute-phase reactivity, 
as  male  hamsters  (but  not  females)  do  manifest  a  moderate  increase  of FP  after 
nonspecific inflammatory stimulae ([1];  and our unpublished observations). 
The abundance of FP in female hamsters suggests that this pentraxin has especial 
functional  significance  in  this  species,  and  was  evolved  for  a  peculiar  biological 
requirement.  If so,  elucidating  the  biological  role  of FP  in  hamsters  may provide 
insight  into  the  function  of pentraxins  in  other  species.  The  high  levels  of FP  in 
females will  be particularly  interesting  if FP  does  have the  biological  activities of 
CRP, such as complement fixation and/or lymphocyte and platelet modulation. If so, 
the normal female Syrian hamster would represent an animal in constant acute-phase 
activation and should normally demonstrate the biological benefits/detriments that 
acute-phase reactants confer to man and the mouse. In this case, one should expect 
obvious  sex  differences  in  biological  responsiveness  to  inflammatory  disease  when 
comparing  female and  male  Syrian  hamsters.  To  our  knowledge,  such  differences 
have  not  been  described.  Similarly,  sex  differences  in  amyloid  accumulation  in 
hamsters has not been published,  although the similarity of FP to SAP would make 
it a  likely candidate  for incorporation  into hamster amyloid. In hamsters, this gene 
apparently  came  under  hormonal  control  in  a  common  ancestor  of  the  Syrian 
(Mesocricetus auratus) and Kurdistan (Mesocricetus brandti) hamster, as both species have 
similar FP, whereas it has not been detected in normal serum of Chinese, Armenian, 
European, and Djzungarian hamsters (52). Perhaps FP is present in low concentration 
in  these  latter  hamsters and  acts  in  a  more typical acute-phase  pattern.  In Syrian 
hamsters,  FP appears to be the sole expression of the ancestral CRP gene, as other 
CRP-SAP-Iike proteins so far have not  been  detected  in  acutely stressed  female or 
male hamsters (our unpublished observations). 
For approximately 50 years, the functional  significance of CRP has eluded inves- J.  E. COE, S.  S.  MARGOSSIAN, H.  S.  SLAYTER, AND JOHN A.  SOGN  989 
tigators although a wide variety of biological effects has been discovered and another 
homologous protein (SAP) has been defined. The present report indicates the existence 
of other  CRP-SAP  homologs  which  superficially  bear  little  resemblance  to  these 
acute-phase  reactants  and  suggests that  a  wide  diversity of proteins  may be found 
within this family. 
Summary 
Female protein (FP), a serum protein present in normal female hamsters was found 
to be similar to acute-phase reactant, C-reactive protein (CRP) and serum amyloid P 
component  (SAP)  in the following ways:  (a)  hamster FP complexed with phospho- 
rylcholine (PC) in a Ca++-dependent fashion as shown by its isolation from serum by 
affinity chromatography with  PC-Sepharose and  selective elution  with  free PC  or 
EDTA;  (b) electron microscopy of FP indicated a pentameric structure similar in size 
and appearance to other pentraxins;  (c)  the parent molecule of FP (150,000 tool wt) 
was composed of five noncovalantly assembled subunits of 30,000 mol wt; and (d) the 
amino acid analysis and terminal NH2 sequence of FP clearly showed homology with 
SAP-CRP. Although FP evolved from an ancestral gene common to SAP and CRP, 
and shares functional, morphological and structural properties with these acute-phase 
proteins,  the  biological  homology of FP  appears  quite  diverse  as  this  protein  is  a 
prominent  serum  constituent  (1-2  mg/ml)  of normal  female hamsters  and  under 
hormonal control (testosterone suppression) in males. 
We thank M. J. Ross and F. Malik for expert technical assistance. 
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